| |
| |
|
| Insider
Information: |
Obrien Christopher Flint |
| Relationship: |
Former Chief Medical O... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
55,946 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,647,818 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,946 |
|
|
| Total
Value |
$7,647,818 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Former Chief Medical O... |
2018-02-06 |
55,946 |
2008-09-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Sr. VP & Chief Medical Officer |
• – – |
2008-09-29 |
4 |
AS |
$4.69 |
$22,628 |
D/D |
(4,824) |
8,509 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr. VP & Chief Medical Officer |
• – – |
2009-01-05 |
4 |
AS |
$3.41 |
$4,992 |
D/D |
(1,462) |
22,449 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2016-11-15 |
4 |
AS |
$52.84 |
$1,321,000 |
D/D |
(25,000) |
30,044 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-01-10 |
4 |
AS |
$43.35 |
$75,863 |
D/D |
(1,750) |
31,794 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-01-17 |
4 |
AS |
$40.66 |
$71,155 |
D/D |
(1,750) |
33,544 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-02-03 |
4 |
AS |
$42.50 |
$63,750 |
D/D |
(1,500) |
35,044 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-02-06 |
4 |
AS |
$43.17 |
$52,063 |
D/D |
(1,206) |
37,038 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr. VP & Chief Medical Officer |
• – – |
2009-03-30 |
4 |
AS |
$3.43 |
$41,661 |
D/D |
(12,151) |
43,631 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-04-12 |
4 |
AS |
$50.41 |
$658,774 |
D/D |
(13,065) |
48,973 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-05-18 |
4 |
AS |
$53.32 |
$5,632,405 |
D/D |
(105,634) |
48,973 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-07-27 |
4 |
AS |
$50.00 |
$436,700 |
D/D |
(8,734) |
48,973 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-09-05 |
4 |
AS |
$57.50 |
$3,036,978 |
D/D |
(52,817) |
48,973 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-10-02 |
4 |
AS |
$61.04 |
$422,702 |
D/D |
(6,925) |
48,973 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-11-02 |
4 |
AS |
$69.71 |
$3,681,641 |
D/D |
(52,817) |
48,973 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2018-01-16 |
4 |
AS |
$79.14 |
$138,499 |
D/D |
(1,750) |
50,723 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr. VP & Chief Medical Officer |
• – – |
2009-09-28 |
4 |
AS |
$3.11 |
$15,129 |
D/D |
(4,859) |
52,106 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr. VP & Chief Medical Officer |
• – – |
2010-01-04 |
4 |
AS |
$2.65 |
$3,983 |
D/D |
(1,503) |
53,937 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Former Chief Medical Officer |
• – – |
2018-02-05 |
4 |
AS |
$83.01 |
$217,341 |
D/D |
(2,613) |
54,310 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2016-08-15 |
4 |
AS |
$48.73 |
$609,125 |
D/D |
(12,500) |
55,044 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-10-02 |
4 |
OE |
$8.65 |
$59,901 |
D/D |
6,925 |
55,898 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Former Chief Medical Officer |
• – – |
2018-02-06 |
4 |
D |
$82.48 |
$83,635 |
D/D |
(1,014) |
55,946 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-11-02 |
4 |
OE |
$8.65 |
$457,320 |
D/D |
52,817 |
56,491 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-07-27 |
4 |
OE |
$8.65 |
$75,549 |
D/D |
8,734 |
57,707 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2016-05-31 |
4 |
AS |
$50.00 |
$625,000 |
D/D |
(12,500) |
67,544 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr. VP & Chief Medical Officer |
• – – |
2010-03-01 |
4 |
AS |
$2.53 |
$34,107 |
D/D |
(13,490) |
73,780 |
0 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
